Cargando…
Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids
Temozolomide is an alkylating cytostatic drug that finds increasing application in the treatment of melanoma, anaplastic astrocytoma and glioblastoma multiforme. The compound is a prodrug that decomposes spontaneously, independent of an enzymatic activation step. DNA methylation induces futile misma...
Autores principales: | Günther, W, Pawlak, E, Damasceno, R, Arnold, H, Terzis, A J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747547/ https://www.ncbi.nlm.nih.gov/pubmed/12569392 http://dx.doi.org/10.1038/sj.bjc.6600711 |
Ejemplares similares
-
Temozolomide induces senescence but not apoptosis in human melanoma cells
por: Mhaidat, N M, et al.
Publicado: (2007) -
Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide
por: Kanzawa, T, et al.
Publicado: (2003) -
Solid stress facilitates spheroid formation: potential involvement of hyaluronan
por: Koike, C, et al.
Publicado: (2002) -
Integration of Endothelial Cells in Multicellular Spheroids Prevents Apoptosis and Induces Differentiation
por: Korff, Thomas, et al.
Publicado: (1998) -
Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?
por: Hirst, T C, et al.
Publicado: (2013)